Preoperative vaginal preparation with povidone-iodine and the risk of postcesarean endometritis

Obstetrics and Gynecology

Volumn 105, Issue 5, 2005, Pages 1024-1029

  Starr, Rosally V ^a   Zurawski, Jill ^a   Ismail, Mahmoud ^a  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFAZOLIN; CLINDAMYCIN; POVIDONE IODINE;

ANEMIA; ANTIBIOTIC PROPHYLAXIS; CESAREAN SECTION; CLAMP; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENDOMETRITIS; FEMALE; FEVER; HUMAN; INTRAUTERINE INFECTION; MAJOR CLINICAL STUDY; MORBIDITY; PATIENT MONITORING; POSTOPERATIVE CARE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; RISK FACTOR; SURGICAL INFECTION; UMBILICAL CORD; VAGINA;

ADULT; ANTI-INFECTIVE AGENTS, LOCAL; CESAREAN SECTION; ENDOMETRITIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; LOGISTIC MODELS; MULTIVARIATE ANALYSIS; POVIDONE-IODINE; PREGNANCY; PREOPERATIVE CARE; REFERENCE VALUES; RISK ASSESSMENT; SURGICAL PROCEDURES, ELECTIVE; SURGICAL WOUND INFECTION;

EID: 17644417444     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: 10.1097/01.AOG.0000164032.16599.7e     Document Type: Article

References (18)

1. Soper DE. Infections following cesarean section. Curr Opin Obstet Gynecol 1993;5:517-20.
2. Gonik B, Shannon RL, Shawar R, Costner M, Seibel M. Why patients fail antibiotic prophylaxis at cesarean delivery: histologic evidence for incipient infection. Obstet Gynecol 1992;79:179-84.
3. Magann EF, Dodson MK, Ray MA, Harris RL, Martin JN, Morrision JC. Preoperative skin preparation and intraoperative pelvic irrigation: impact on post-cesarean endometritis and wound infection. Obstet Gynecol 1993;81:922-5.
4. Chang PL, Newton ER. Predictors of antibiotic prophylactic failure in post-cesarean endometritis. Obstet Gynecol 1992;80:117-22.
5. Watts DH, Hillier SL, Eschenbach. Upper genital tract isolates at delivery as predictors of post-cesarean infections among women receiving antibiotic prophylaxis. Obstet Gynecol 1991;77:287-92.
6. Gabbe SG, Niebyl JR, Simpson JL, editors. Obstetrics: normal and problem pregnancies. 3rd ed. London (UK):Churchill Livingstone, Inc.; 1996.
7. Watts DH, Krohn MA, Hillier SL, Eschenbach DA. Bacterial vaginosis as a risk factor for post-cesarean endometritis. Obstet Gynecol 1990;75:52-8.
8. Roberts S, Maccato M, Faro S, Pinell P. The microbiology of post-cesarean wound morbidity. Obstet Gynecol 1993;81:383-6.
9. Berenson AB, Hammill HA, Martens MG, Faro S. Bacteriologic findings of post-cesarean endometritis in adolescents. Obstet Gynecol 1990;75:627-9.
10. Eason EL, Sampalis JS, Hemmings R, Joseph L. Povidone-iodine gel vaginal antisepsis for abdominal hysterectomy. Am J Obstet Gynecol 1997;176:1011-6.
11. Osborne NG, Wright RC. Effect of preoperative scrub on the bacterial flora of the endocervix and vagina. Obstet Gynecol 1977;50:148-50.
12. Amstey MS, Jones AP. Preparation of the vagina for surgery: a comparison of povidone-iodine and saline solution. JAMA 1981;245:839-41.
13. Reid VC, Hartmann KE, McMahon M, Fry EP. Vaginal preparation with povidone iodine and postcesarean infectious morbidity: a randomized controlled trial. Obstet Gynecol 2001;97:147-52.
14. Cunningham FG, Gant NF, Leveno KJ, Gilstrap LC III, Hauth JC, Wenstrom KD, editors. Williams obstetrics. 21st ed. New York (NY): McGraw-Hill; 2001.
15. Schrag S, Gorwitz R, Fultz-Butts K, Schuchat A. Prevention of prenatal Group B Streptococcal disease. Revised guidelines from CDC. MMWR Recomm Rep 2002;51(RR-11):1-22.
16. Haeri AD, Kloppers LL, Forder AA, Baillie P. Effect of different pre-operative vaginal preparations on morbidity of patients undergoing abdominal hysterectomy. S Afr Med J 1976;50:1984-6.
17. Pitt C, Sanchez-Ramos L, Kaunitz AM. Adjunctive intravaginal metronidazole for the prevention of postcesarean endometritis: a randomized controlled trial. Obstet Gynecol 2001;98:745-50.
18. Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995;273:408-12.